Back to search

National and Kapodistrian University of Athens

Μελέτη της στάγδην ενδοφλέβιας χορήγησης λιδοκαΐνης στη θεραπεία του νευροπαθητικού πόνου

Abstract

dc:description

Background: Trigeminal Neuralgia (TGN) is the most common kind of neuropathic pain. Its therapeutic approach is challenging as the first line treatment often does not help or causes intolerable side effects. The current study examines whether intravenous lidocaine as additive treatment affects the spontaneous and evoked pain (allodynia/hyperalgesia) of TGN.Methods: Twenty patients suffering from TGN were enrolled to a randomized double- blind crossover trial. Each patient underwent two active and two placebo infusions of 5 mg/kgr lidocaine in 250 ml serum normal (S/N) ) 0.9% or S/N 0,9% alone, over 60 minutes. At baseline, immediately and the next morning after the infusion we assessed spontaneous pain using visual analog scale (VAS) and evoked pain and hyperalgesia by thermal, cold, pressure application and pinprick tests. For the Quantitative Sensory Testing the Neurometer (R-CPT) was used. We documented the side effects of the treatment during the infusion and for 24 hours. STATA version 11.0 was used for the statistical analysis.Results: Both lidocaine and placebo reduced VAS score at the end and until the next morning of the infusion (p<0,001) although lidocaine was superior to placebo. The side effects of lidocaine (mild confusion, somnolence, dry mouth etc) were mild, not especially troubling, thus we did not have any drop outs. Clinical tests showed that lidocaine reduced mechanical, thermal and cold allodynia more than placebo, while placebo reduced only mechanical and thermal, but not cold allodynia, in a lesser degree than lidocaine (p<0.05). Concerning evoked pain the values received by the R-CPT were increased at baseline, both at the painful and at the contra lateral side at 5, 250, 2000 Hz before treatment, and got higher at 5 and 250 Hz after the lidocaine infusion at the painful side, whereas after placebo they were reduced (p<0,001).Conclusion: Lidocaine ameliorated spontaneous and evoked pain of TN more than placebo for almost 24 hours, without serious side effects, suggesting that it could offer an extra and safe therapeutic option as an add on therapy in intractable neuropathic pain because of trigeminal neuralgia.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stavropoulou, Evmorfia
  • Σταυροπούλου, Ευμορφία

Subjects

dc:subject × 16

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40683

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stavropoulou, Evmorfia; Σταυροπούλου, Ευμορφία. Μελέτη της στάγδην ενδοφλέβιας χορήγησης λιδοκαΐνης στη θεραπεία του νευροπαθητικού πόνου. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/40683